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murine gut microbiota is important to gain a better mechanistic understanding. Continuous in vitro
fermentation models are powerful tools to investigate microbe-microbe interactions while circumventing
animal testing and host confounding factors, but are lacking for murine gut microbiota. We therefore
developed a novel continuous fermentation model based on the PolyFermS platform adapted to the murine
caecum and inoculated with immobilized caecal microbiota. We followed a stepwise model development
approach by adjusting parameters [pH, retention time (RT), growth medium] to reach fermentation
metabolite profiles and marker bacterial levels similar to the inoculum. The final model had a stable
and inoculum-alike fermentation profile during continuous operation. A lower pH during startup and
continuous operation stimulated bacterial fermentation (115 mM short-chain fatty acids at pH 7 to 159
mM at pH 6.5). Adjustments to nutritive medium, a decreased pH and increased RT helped control the
in vitro Enterobacteriaceae levels, which often bloom in fermentation models, to 6.6 log gene copies/mL
in final model. In parallel, the Lactobacillus, Lachnospiraceae, and Ruminococcaceae levels were better
maintained in vitro with concentrations of 8.5 log gene copies/mL, 8.8 log gene copies/mL and 7.5 log
gene copies/mL, respectively, in the final model. An independent repetition with final model parameters
showed reproducible results in maintaining the inoculum fermentation metabolite profile and its marker
bacterial levels. Microbiota community analysis of the final model showed a decreased bacterial diversity
and compositional differences compared to caecal inoculum microbiota. Most of the caecal bacterial
families were represented in vitro, but taxa of the Muribaculaceae family were not maintained. Functional
metagenomics prediction showed conserved metabolic and functional KEGG pathways between in vitro
and caecal inoculum microbiota. To conclude, we showed that a rational and stepwise approach allowed
us to model in vitro the murine caecal microbiota and functions. Our model is a first step to develop
murine microbiota model systems and offers the potential to study microbiota functionality and structure
ex vivo.
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Murine models are valuable tools to study the role of gut microbiota in health or disease.
However, murine and human microbiota differ in species composition, so further
investigation of the murine gut microbiota is important to gain a better mechanistic
understanding. Continuous in vitro fermentation models are powerful tools to investigate
microbe-microbe interactions while circumventing animal testing and host confounding
factors, but are lacking for murine gut microbiota. We therefore developed a novel
continuous fermentation model based on the PolyFermS platform adapted to the murine
caecum and inoculated with immobilized caecal microbiota. We followed a stepwise
model development approach by adjusting parameters [pH, retention time (RT), growth
medium] to reach fermentation metabolite profiles and marker bacterial levels similar to
the inoculum. The final model had a stable and inoculum-alike fermentation profile during
continuous operation. A lower pH during startup and continuous operation stimulated
bacterial fermentation (115 mM short-chain fatty acids at pH 7 to 159 mM at pH 6.5).
Adjustments to nutritive medium, a decreased pH and increased RT helped control the
in vitro Enterobacteriaceae levels, which often bloom in fermentation models, to 6.6
log gene copies/mL in final model. In parallel, the Lactobacillus, Lachnospiraceae, and
Ruminococcaceae levels were better maintained in vitro with concentrations of 8.5 log
gene copies/mL, 8.8 log gene copies/mL and 7.5 log gene copies/mL, respectively,
in the final model. An independent repetition with final model parameters showed
reproducible results in maintaining the inoculum fermentation metabolite profile and
its marker bacterial levels. Microbiota community analysis of the final model showed
a decreased bacterial diversity and compositional differences compared to caecal
inoculum microbiota. Most of the caecal bacterial families were represented in vitro,
but taxa of the Muribaculaceae family were not maintained. Functional metagenomics
prediction showed conserved metabolic and functional KEGG pathways between in vitro
and caecal inoculum microbiota. To conclude, we showed that a rational and stepwise
approach allowed us to model in vitro the murine caecal microbiota and functions. Our
model is a first step to develop murine microbiota model systems and offers the potential
to study microbiota functionality and structure ex vivo.
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INTRODUCTION
The gastrointestinal tract of the mammalian host is inhabited
by a dense, complex and diverse bacterial community, termed
the gut microbiota (Robles Alonso and Guarner, 2013). The gut
microbiota is involved in key processes beneficial for the host
such as dietary compound metabolism, pathogen displacement,
or immune system development (Round and Mazmanian, 2009;
Robles Alonso and Guarner, 2013). A large proportion of the
vast amount of evidence that the gut microbiota influences
many physiological and pathological processes in the host
comes from murine studies (Round and Palm, 2018). Mouse
models are a valuable tool for human biology, disease and
pharmaceutical research due to the high similarity in physiology,
anatomy, and genetics (Nguyen et al., 2015). However, mice and
humans differ in gastrointestinal tract anatomy, dietary habits,
circadian rhythm, and environmental microbes and pathogens,
which leads to differences in their gut microbiota composition
and activity (Nguyen et al., 2015; Uhl and Warner, 2015;
Hugenholtz and de Vos, 2017).
In humans, the large intestine is the main site of fermentation,
and contains the highest microbial load and activity, whereas
in mice, intestinal fermentation mainly takes place in the
caecum, a “bag-like” link between the small intestine and the
colon that is nearly absent in humans (Nguyen et al., 2015).
Morphological differences in compartmentalization, retention
times (RTs) and mixing conditions likely influences composition,
richness and diversity of the gut microbiota in humans and mice
(Nguyen et al., 2015). In both humans and mice, fermentation
of indigestible food compounds produces the short-chain
fatty acids (SCFAs) acetate, propionate and butyrate (Flint
et al., 2012; Burokas et al., 2017; Herrmann et al., 2018). The
bacterial composition influences the fermentation capacity
and end microbial metabolite profiles (Flint et al., 2012). At
phylum level, the murine and human intestinal microbiota
are similar with the two dominating phyla Firmicutes and
Bacteroidetes (Ley et al., 2006; Clavel et al., 2016; Hugenholtz
and de Vos, 2017). However, when comparing the bacterial
composition at a deeper phylogenetic level, mice and humans
show clear differences in genera composition and abundance.
First comparisons showed that 85% of detected bacterial genera
in the mouse gut are not present in that of humans (Ley et al.,
2005) and further studies identified mouse- and human-specific
taxa (Nguyen et al., 2015; Xiao et al., 2015; Clavel et al., 2016).
Genera such as Lactobacillus, Turicibacter and Coprobacillus
(Erysipelotrichaceae), Anaerotruncus (Ruminococcaceae),
Marvinbryantia (Lachnospiraceae), and Pseudoflavonifractor
(unclassified Clostridiales) are present at higher levels in the
murine intestinal microbiota, while Prevotella, Faecalibacterium,
Ruminococcus, Oscillibacter, and Klebsiella are more abundant
in human (Nguyen et al., 2015; Xiao et al., 2015). Deep
metagenome sequencing revealed that only 4% of microbial
genes in the mouse gut were shared with human gut samples,
but almost 80% of their annotated functions were common
(Xiao et al., 2015). This indicates a similar functionality of
mouse and human gut microbiota, but performed by different
species and strains.
Recently, efforts were made to isolate the murine gut
bacteria (Lagkouvardos et al., 2016) to formulate minimal
microbial consortia for studying microbiota-derived functions
in gnotobiotic mouse models (Clavel et al., 2017). Simplified
defined consortia may not recapitulate all functions of complex
microbiota. Continuous in vitro fermentation models that
contained the complex gut microbial communities mimicking
the conditions of the modeled host were successful developed
for ecological and mechanistic studies of human (Zihler et al.,
2013; Dostal et al., 2015; Geirnaert et al., 2015; Lacroix et al.,
2015; McDonald et al., 2015) and monogastric animal (Tanner
et al., 2014) gut microbiota, which avoided ethical concerns
and host confounding factors. However, to our knowledge no
complex murine gut microbiota model has been developed, apart
from simple, closed and short-term batch cultures (Salyer et al.,
2013; Herrmann et al., 2017; Li et al., 2018) or continuous
flow cultures without pH control and taxonomic validation
(Freter et al., 1983). In contrast to batch cultures, continuous
fermentation models offer the advantage of continuous substrate
supply and removal of toxic fermentation products, which
are required for growth and establishment of balanced and
representative ecosystems. Physiological parameters like RT,
temperature, pH, and redox potential are highly controlled in
continuous fermentation, which facilitates the establishment of
steady-state conditions (Payne et al., 2012). In addition, in vitro
continuous gut fermentation models may allow simulation of
the spatial, environmental and temporal features of a specific
gut environment. Challenges of in vitro fermentation models
include the large amount of gut microbiota sample (mainly
feces) required for inoculation and the loss of less competitive
bacteria by rapid washout. To address these challenges, fecal
microbiota can be immobilized in porous gel beads and run
in continuous culture, which allows models to operate at high
cell density akin to the gut, prevents washout of slow growing
bacteria, and reproduces both planktonic and sessile states of
the gut microbiota (Zihler et al., 2013; Tanner et al., 2014;
Fehlbaum et al., 2015; Poeker et al., 2018). In addition, only
very small amounts of donor material (1–2 g) are required to
establish a fermentation, therefore enabling modeling of small
animal gut microbiota.
In this study, we developed a continuous fermentation model
of the murine caecal microbiota based on the PolyFermS platform
inoculated with immobilized caecal microbiota of C57BL/6 mice.
In a first step, we determined the pH, the bacterial composition
and the metabolic profile in the caeca of C57BL/6 mice. To
support growth of the murine caecal bacterial populations
and activity, a complex murine nutritive growth medium was
developed to mimic substrate conditions encountered in mouse
caecum chyme. Different factors of the fermentation model,
including caecum sampling, fermentation starting mode, pH,
RT and adjustment of growth medium were investigated and
adjusted in a sequential order, using five different models
inoculated with different pooled fresh immobilized caecum
microbiota from 4-5 mice and operated up to 69 days. The
microbiota composition in the reactor eﬄuents was analyzed
by quantitative real time PCR (qPCR) and 16S rRNA amplicon
sequencing and compared with the caecal inoculum. Metabolic
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Healthy female WT C57BL/6J mice aged 9–13 weeks were
obtained from Charles River (Lyon, France) and housed in
groups at University Hospital of Zurich. Housing conditions
were controlled at 22◦C, room humidity and 12 h light/dark
cycle. Mice were provided with mouse/rat maintenance chow
(Kliba Nafag, Kaiseraugst, Switzerland) and ad libitum drinking
water. Mice were housed in different cages and were sacrificed
on the same day in the morning by cervical dislocation, after
which the caecum was immediately removed and placed on a
sterile petri plate. The pH of the fresh caecal content in the
intact caecal pouch was immediately determined using a probe
pre-calibrated pH meter (Metrohm 744 pH Meter, Metrohm
Ltd., Herisau, Switzerland). The caecal content was collected into
DNAase-free tubes, immediately snap frozen in liquid nitrogen,
and then stored at −20◦C until DNA and SCFA extraction.
Mouse experiments were conducted according to Swiss animal
welfare legislation, and the local veterinary office approved all
procedures (Veterinäramt des Kantons Zürich; Nr. ZH220/2016).
In vitro Fermentation Model
Nutritive Medium
The nutritive medium was formulated from the validated
bacterial growth medium described by Macfarlane et al. (1998)
for cultivating the human gut microbiota in vitro. It was
modified to approximate the carbohydrate and protein ratio
in murine caecum chyme. Standard mouse chow is composed
of approximately 18% (w/w) protein, 54% (w/w) soluble
carbohydrate and 4.5% (w/w) crude fiber (Supplementary
Table S1B). Considering an average daily chow intake of
3.5 g per C57BL/6J mouse (Champy et al., 2008), a daily
carbohydrate intake of 1.9 g, 0.6 g protein and 0.14 g crude
fibers was considered. To calculate the amount of carbohydrates
(excluding crude fibers) and proteins reaching the caecum, upper
gastrointestinal digestibility indices of 95% for carbohydrates
(Dahlqvist and Thomson, 1963a,b; Lee et al., 2011) and 90%
for proteins (Kerr et al., 2014) were applied. This resulted in
0.09 g of dietary carbohydrates and 0.06 g of dietary proteins
reaching the caecum each day or a dietary carbohydrate:protein
ratio of 60:40. Macfarlane medium was adapted accordingly.
(Supplementary Table S1A). To simulate the mouse chow
more closely, we excluded guar gum and inulin, and replaced
soluble potato starch with soluble corn starch. Concentrations
of the protein sources casein, peptone, tryptone and yeast
extract were increased to meet the calculated murine caecum
chyme protein concentration. The mucin concentration was
kept at 4 g/L. The pectin concentration was kept at 2 g/L to
avoid flow disturbance in tubes from increased viscosity. The
carbohydrate:protein ratio was approximately 60:40 in medium
1 and 55:45 in medium 2 (Supplementary Table S1A), which did
not include the contribution of yeast extract and mucin used for
simulating the endogenous protein and carbohydrate sources in
the gastrointestinal tract (Cornick et al., 2015). After sterilization
(20 min, 120◦C) and cooling to 4◦C, 1 mL of a filter-sterilized
(0.2 µm pore-size) vitamin solution (Michel et al., 1998) was
added to the medium. For initial bead colonization, the nutritive
growth medium was supplemented with 20% (v/v) eﬄuent
from a previous fermentation (acetate:propionate:butyrate
2.5:1.5:1) or 20% (v/v) rumen fluid (4.5:3:1) and 0.1% (m/v)
cellobiose (Table 1A). All components were purchased from
Sigma-Aldrich Chemie (Buchs, Switzerland), except for xylane
(Angene, London, United Kingdom), peptone water (Oxoid
AG, Pratteln, Switzerland), bile salts (Oxbile, Oxoid AG),
tryptone (BD, Sparks, United States), yeast extract (Merck,
Darmstadt, Germany), NaHCO3 (Fischer Scientific, Pittsburgh,
PA, United States), NaCl and KH2PO4 (VWR International
AG, Dietikon, Switzerland), MgSO4·anhydrous (Acros Organics,
Geel, Belgium) and MnCl2·4H2O (Fluka, Buchs, Switzerland).
Caecal Microbiota Immobilization and Bead
Colonization
For each immobilization procedure, four to five caeca from healthy
9- to 13- weeks old female C57BL/6 mice were collected to prepare
the inoculum. All caecal contents were collected in the morning
shortly (models 1 and 2) or a couple of hours (models 3–5) after the
dark period. In model 1, caecal contents were dissected aerobically
from the remaining gastrointestinal tract with surgical scissors,
placed onto a sterile Petri dish and immediately transferred
to an anaerobic box until further processing. In models 2–5,
the caeca were tied off with surgical threads to avoid oxygen
stress to the microbiota, placed onto a sterile Petri dish and
immediately transferred to an anaerobic jar, and transferred into
an anaerobic chamber (10% CO2, 5% H2, and 85% N2) (Coy
Laboratories, Ann Arbor, MI, United States), for dissection and
pooling contents. In models 3–5, caecal bacteria were washed
with pre-reduced peptone water (0.1 %, pH 7, Thermo Fisher
Diagnostics AG, Pratteln, Switzerland) before immobilization to
remove potential interfering endogenous enzymes, salts and other
cellular products that hinder proper gel bead formation. Caecal
bacteria were immobilized in 1–2 mm gel beads consisting of
gellan gum (2.5%, m/v), xanthan (0.25%, m/v), and sodium citrate
(0.2%, m/v) in an anaerobic chamber as previously described
(Poeker et al., 2018). Sixty milliliters of freshly produced caecal
beads were transferred to a glass bioreactor containing 140 mL
of sterile murine nutritive medium. For initial bead colonization,
two or three consecutive fed-batch fermentations were carried
out by replacing 100 mL of the spent medium by fresh nutritive
medium every 6–24 h, depending on the model (Table 1A). The
reactor headspace was continuously flushed with CO2, to ensure
anaerobiosis in the system. The temperature was controlled at
37◦C and the pH at selected values (depending on the model
and fermentation step) by automatic addition of 2.5 M NaOH.
Continuous Caecum Microbiota Fermentation and
Treatments
After batch fermentations, the reactor containing caecal beads
was switched to continuous mode by continuously supplying
fresh, sterile and anaerobic nutritive medium and removing
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TABLE 1 | Conditions of initial batch (bead colonization) (A) and continuous (B) fermentation for the different tested models of mouse caecal fermentation.
(A) Batch conditions
Model 1 Model 2 Model 3 Model 4 Model 5 Models 5∗
Nutritive medium∗ 6.8 g/L starch 6.8 g/L starch 6.8 g/L starch 2 g/L starch 2 g/L starch 2 g/L starch





(Batch 1 and 2) 20%
rumen fluid (Batch 1)
0.1%cellobiose
(Batch 1 and 2) 20%
rumen fluid (Batch 1)
PH 7 7 7 5.8 6 6
Fed-batch times
Batch 1 24 h 24 h 16 h 20 h 20 h 20 h
Batch 2 24 h 24 h 5 h 6 h, 8 h 8 h
Batch 3 6 h 6 h
(B) Continuous fermentation conditions
Model 1 Model 2 Model 3 Model 4 Model 5 Models 5∗
Nutritive medium∗ 6.8 g/L starch 6.8 g/L starch 6.8 g/L starch 2 g/L starch 2 g/L starch 2 g/L starch
pH 7 7 7 6.5 6.5 6.5
Retention time 9 h 9 h 9 h 9 h 12 h 12 h
Total fermentation time (days) 13 44 32 53 69 42
∗Composition presented in Supplementary Table S1.
an equivalent volume of fermented medium with peristaltic
pumps (Reglo, Ismatec, Glattbrugg, Switzerland) (Table 1B).
For all bioreactors, stirring speed was carried out at 180 rpm,
working volume was 200 mL, temperature was set to 37◦C
and anaerobiosis was maintained by continuously flushing the
headspace of bioreactors. In models 1–3, bioreactors were
operated with constant conditions of pH 7 and a continuous flow
rate of 22.2 mL/h (RT of 9 h) of medium 1 (6.8 g/L starch).
Bioreactor in model 4 was maintained at pH 6.5 and supplied
with fresh nutritive medium 2 (2 g/L starch) at a RT of 9 h.
In model 5 and model 5∗, reactors were operated with constant
conditions of pH 6.5 and a continuous flow rate of 16.7 mL/h
(corresponds to a RT of 12 h) of medium 2. Eﬄuent samples
were taken daily and separated into bacterial pellets (10 min at
14,000 × g at 4◦C) and supernatant, and stored at −20◦C until
further analysis. Stability of in vitro microbiota was monitored
by daily measurements of the main fermentation metabolite
concentrations in sample supernatants.
Microbial Metabolite Analysis
Caecal samples were mixed with 300 µL 0.15 mM H2SO4,
homogenized and centrifuged at 4◦C at 9000 × g for 20 min.
Supernatant was filtered directly into HPLC vials through a
0.45 µm nylon membrane (Infochroma AG, Zug, Switzerland).
Fermentation samples were centrifuged at 4◦C at 14,000 × g
for 10 min. The pellet was used for DNA extraction and the
supernatant was filtered into glass vials through a 0.45 µm
nylon membrane. HPLC analysis (Thermo Fisher Scientific
Inc. Accela, Wohlen, Switzerland) was performed to determine
the concentrations of SCFAs (formate, propionate, acetate,
butyrate, and valerate), branched-chain fatty acids (BCFAs)
(isobutyrate and isovalerate) and intermediate metabolites
(lactate and succinate). Analyses were performed with an
Accela Chromatography System and RI-detector (Thermo Fisher
Scientific Inc., Reinach, Switzerland), equipped with a Security
Guard Carbo-H cartridge (4 × 3.0 mm) and a Rezex ROA-
Organic Acid H+ column (300 × 7.8 mm). Volumes of 40 µL
were injected into the HPLC with a flow rate of 0.4 mL/min and
H2SO4 as an eluent (Poeker et al., 2018).
Microbial Community Analysis
Genomic DNA Extraction
Total genomic DNA was extracted from 100 to 200 mg of caecal
contents and the pellet of 2 mL of fermentation eﬄuent using the
FastDNA R© SPIN Kit for Soil (MP Biomedicals, Illkirch Cedex,
France) according to the manufacturer’s instructions. Total
DNA concentration was measured by spectrophotometry using
a Nanodrop R©ND-1000 Spectrophotometer (Wiltec AG, Littau,
Switzerland) and samples were stored at−20◦C until analysis.
Quantitative PCR Analysis
DNA extracts were used for qPCR to enumerate the
gene copy numbers of total bacteria and the specific
marker bacterial groups Firmicutes, Ruminococcaceae,
Lachnospiraceae, Lactobacillus–Leuconostoc–Pediococcus,
Bacteroidetes, Bacteroides, Enterobacteriaceae, and Akkermansia
(Supplementary Table S2). qPCR assays were performed using
1 µL of 10- or 100- fold diluted genomic DNA, 2x SYBR
Green qPCR Mastermix (Life Technologies, Labgene Scientific
Instruments, Zug, Switzerland), 100 µM of each forward
and reverse primer, resulting in a total volume of 25 µL in a
96-well plate. The analysis was performed in an ABI PRISM
7500-PCR -sequence detection system (Applied Biosystems,
Zug, Switzerland). Each reaction was run in duplicate. For
quantification, a dilution series of standards was obtained by
amplification of the linearized plasmids containing the gene of
a representative bacterial species belonging to the target group,
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and included in each run (Pham et al., 2017). Primer specificity
and verification of the presence of the desired amplicon was
determined by melting curve analysis. PCR efficiency (%) was
calculated from the slope of the standard curve of each qPCR
assay. Assays with an efficiency of 80–110% (slope of 3.2–3.9)
were included in data analysis.
Microbiota Profiling With 16S rRNA Amplicon
Sequencing
The bacterial community in caecal samples was analyzed
using the primers 341F (5′-CCTAYGGGRBGCASCAG-3′)
and 806R (5′-GGACTACNNGGGTATCTAAT-3′), which
flank the V3-V4 region. MiSeq adaptors were added by PCR.
Sequencing of caecum microbiota of different mice was
performed with Illumina MiSeq (Genotoul, Castanet-Tolosan
Cedex Mainz, France). For the microbiota analysis of caecal
inocula and fermentation samples of the final models 5 and
5∗, the V4 region of the 16S rRNA gene was amplified with
primers 515F (5′-GTGCCAGCMGCCGCGGTAA-3′) and
806R (5′-GGACTACHVGGGTWTCTAAT-3′). Sequencing was
performed with Illumina MiSeq (Genomic Diversity Centre,
ETH Zurich, Zurich, Switzerland) with V2 reagent kit for
2 × 250 bp paired end Next Tera chemistry supplemented with
20% of PhiX. The raw sequence data has been submitted to
European Nucleotide Archive (ENA) database with accession
number PRJEB30419. The open-source bioinformatics pipeline
Quantitative Insight Into Microbial Ecology (QIIME) (Caporaso
et al., 2010) was used to process the raw 16S rRNA gene
sequencing data. The raw dataset containing pair-ended reads
with corresponding quality scores were merged and trimmed
using fastq_mergepairs and fastq_filter scripts implemented
in the UPARSE pipeline (Edgar, 2013) as previously described
(Krych et al., 2018). The minimum overlap length of trimmed
reads was set to 50 bp (V4) or 20 bp (V3V4). The minimum
length of merged reads was 180 bp (V4) or 200 bp (V3V4),
the max expected error E = 2.0, and first truncating position
with quality score N ≤ 4. Purging the dataset from chimeric
reads and constructing de novo Operational Taxonomic
Units (OTU) were conducted using the UPARSE pipeline
(Edgar, 2013). The green genes 16S rRNA gene collection
(version 13.8) was used as a reference database (Werner
et al., 2012) and an OTU count table including taxonomy
was generated. The OTUs assigned to the S24-7 family were
reported in the manuscript as taxa of the Muribaculaceae
family (Lagkouvardos et al., 2016). QIIME open source
software package (1.8.0 and 1.9.0) was used for subsequent
analysis, including alpha and beta diversity, and the PICRUSt
(phylogenetic investigation of communities by reconstruction
of unobserved states) (Langille et al., 2013) analysis to predict
the KEGG metabolic pathways and COG functional groups from
microbiota samples.
Statistical Analysis
To compare SCFA concentrations between fermentation
models, statistical tests were carried out using SigmaPlot
13.0 (SigmaPlot Software, La Jolla, CA, United States).
Significance level was set at 0.05. Normality of the data
set was tested with the Kolmogorov–Smirnov test. In
case of normality, mean values of two different groups
were compared with an independent samples t-test. In
case of non-normality, differences were tested with non-
parametric Mann–Whitney U test. Data are expressed
as means ± standard deviations (SD) of 3 days of the
stabilization and treatment periods with standard observed
variations of metabolites lower than 10% in the same
reactor in each fermentation. To assess if there were
significant differences in taxa abundance between caecal
inoculum and PolyFermS microbiota, or between different
PolyFermS microbiota, the DESeq2 method (Love et al.,
2014) was used on the unnormalized count data as previously
suggested by McMurdie and Holmes (2014).
RESULTS
In the first step, caecal physiological parameters such as
pH, bacterial fermentation metabolites and composition
were investigated for the C57BL/6 mouse strain. This
breed was selected to inoculate the fermenters because
it is the most widely used strain in biomedical and gut
microbiota research (Bryant, 2011). To establish the in vitro
murine caecal microbiota model, we analyzed fermentation
metabolites by HPLC and quantified specific bacterial
populations, particularly the stress- and oxygen-sensitive
families Lachnospiraceae and Ruminococcaceae, and the genus
Lactobacillus by qPCR as main markers for representative
bacterial groups of murine gut microbiota. Overgrowth of
the Enterobacteriaceae family was also monitored to detect
a potential lack of control of oxygen stress during sampling
and start-up of fermentation. These microbial indicators were
used to suggest subsequent changes during the sampling,
bead colonization and continuous fermentation process
to achieve a balance akin to the mouse caecum content
used for immobilization and inoculation of the continuous
fermentation model. The final conditions set for model 5
were repeated with two caecal inocula prepared from different
mice (model 5∗).
Composition of Caecal WT C57BL/6
Mouse Microbiota and Metabolites
Caecal pH in WT C57BL/6 mice (n = 15) ranged from
6.2 to 6.9 with a mean of 6.5 ± 0.2 (Figure 1A). Caecal
fermentation metabolites; the SCFAs acetate, propionate
and butyrate; the intermediates succinate and lactate;
and the BCFA isobutyrate, were detected in all murine
caeca (Figure 1B). Important individual variations of total
metabolite concentration (17.7–74.1 µmol/g; average of
56.7 ± 14.6 µmol/g), and of the main end metabolites
acetate (28.5 ± 5.0 µmol/g), propionate (5.1 ± 1.4 µmol/g)
and butyrate (23.5 ± 5.9 µmol/g) were measured, while
succinate (between 1 and 11 µmol/g), lactate (1–2 µmol/g), and
isobutyrate (1–2 µmol/g) were detected at lower concentrations.
The average acetate:propionate:butyrate ratio was 50:9:41,
which was in the range of previous reports in same mouse
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FIGURE 1 | Analysis of caecal contents of WT C57BL/6 mice (means ± SEM; n = 15). (A) pH; (B) Metabolite concentrations (µmol/g); (C) Microbial composition
obtained by 16S rRNA amplicon sequencing and expressed as relative abundance at phylum and (D) family level. Data are mean ± SEM. Values < 1% are
summarized in the group «Others».
strain on similar chow (Krautkramer et al., 2017). Caecal
microbiota were dominated by bacterial phyla Firmicutes
(56.0 ± 8.0%) and Bacteroidetes (38.9 ± 7.3%), and also
harbored Proteobacteria at lower levels (4.6± 1.3%) (Figure 1C).
Within Bacteroidetes, Muribaculaceae (S24-7) and Rikenellaceae
were the most abundant families, and within the Firmicutes
an unclassified Clostridiales family, Lachnospiraceae and
Ruminococcaceae (Figure 1D). The α-diversity Shannon index
(H) ranged from 5.6 to 6.2 (average 5.9 ± 0.9) (data not
shown). Principal Coordinate Analysis (PCoA) was used to
analyze β-diversity to characterize the degree of individual
variations among the caecal murine microbial communities.
Mice of the same age co-housed within the same cage for
21 days or in different cages were analyzed. The caecal
microbiota of mice housed in the same cage did not cluster and
individual mouse microbiota scattered in both unweighted
and weighted Unifrac distance PCoA (Supplementary
Figure S1), indicating a large inter-individual variation in
caecal microbiota composition.
Development of in vitro Model for Murine
Caecal Microbiota Fermentation
During bead colonization, the effects of pH in combination with
different nutritive media as well as initial batch fermentations
conditions for bead colonization were assessed. During
continuous operation, the impact of pH in combination with
different RTs were investigated to improve maintenance of
activity and composition of the murine caecal microbiota in vitro
and compare to in vivo caecum data.
In model 1, caecal content sampling and processing was
performed rapidly but under aerobic conditions and bead
colonization was done at pH 7 in nutritive medium 1
supplemented with 20% (v/v) fermentation eﬄuent during
Frontiers in Microbiology | www.frontiersin.org 6 May 2019 | Volume 10 | Article 1166
fmicb-10-01166 May 27, 2019 Time: 17:10 # 7
Poeker et al. In vitro Caecal Murine Fermentation Model
three batch cultures (Table 1A). During continuous operation,
constant conditions of pH 7 and RT 9 h were used. Metabolic
stability was observed after 4 days of continuous fermentation
with a mean total metabolite concentration of 115± 10 mM from
day 4 to day 12 (Figure 2A and Supplementary Figure S2A).
Acetate (65 ± 4 mM) was the main produced metabolite,
followed by butyrate (14 ± 3 mM) and propionate (15 ± 4 mM)
(Supplementary Table S3). We observed higher levels of lactate,
an intermediate fermentation metabolite, in the caecal inoculum
compared to the first sampled caecal contents (Figure 1B) and
compared to in vitro levels (Figure 2A). This might be because
caecal contents for model 1 were sampled in the morning
shortly after dark period and it was previously observed that
lactate levels were then highest (Hamaguchi et al., 2015; Tahara
et al., 2018). At the bacterial compositional level, a decrease
in butyrate-producing families Ruminococcaceae (−1.2 log gene
copies) and Lachnospiraceae (−0.6 log gene copies) was observed
compared to the corresponding caecal inoculum (Figure 2B and
Supplementary Table S4). Lactobacillus spp. were also decreased
in vitro compared to the caecal inoculum (−2.4 log gene copies
vs. in vivo), while Enterobacteriaceae were increased (+1.5 log
gene copies vs. in vivo).
We assumed that the short exposure to oxygen during sample
collection favored the growth of facultative anaerobes, including
Enterobacteriaceae and was detrimental to strict anaerobes such
as bacterial taxa within Clostridiales. Therefore, in model 2 the
sampling procedure was adapted to better protect the microbiota
from oxygen. In addition, the batch fermentation medium was
supplemented with lactate to enhance the growth and activity of
lactate-consuming butyrate-producers within the bacterial order
Clostridiales (Bourriaud et al., 2005; Tao et al., 2016). Metabolic
stability of model 2 was reached after 12 days of continuous
operation (Figure 2A and Supplementary Figure S2B) with
mean total metabolite production of 114 ± 3 mM. In
model 2, an acetate:propionate:butyrate (AA:PA:BA) ratio of
61:24:15 was observed, with slightly increased propionate levels
compared to the caecal inoculum (73:15:12) (Supplementary
Table S3). Compared to the caecal microbiota inoculum,
Enterobacteriaceae (+0.7 log gene copies) were increased in
model 2 eﬄuents, while Lactobacillus spp. (−3.1 log gene
copies) and butyrate-producers (Lachnospiraceae: −0.5 log gene
copies; Ruminococcaceae: −0.6 log gene copies) were decreased
(Figure 2B and Supplementary Table S4).
The medium of model 3 was supplemented with both
cellobiose and rumen fluid to improve bead colonization of
butyrate-producing bacteria and to enhance the growth of
Lactobacillus spp. Rumen fluid contains primary nutrients
for cross-feeding and microbial growth factors (Bryant, 1959;
Kamada et al., 2013; van Zanten et al., 2014). In addition,
the number of bead colonization batch fermentations was
reduced to two, and the duration for the first batch was
extended to 16 h to decrease the growth advantage of fast-
growing Enterobacteriaceae, promote growth and activity
of butyrate-producing bacteria (Clostridia), and achieve a
more complete carbohydrate fermentation with high re-
utilization of intermediate metabolites (lactate, formate, acetate,
succinate). Metabolic stability of model 3 was reached after
15 days, with a higher mean total metabolite concentration
(135 ± 4 mM) compared to model 2 (p < 0.05) and model
1 (p < 0.05) and a AA:PA:BA molar ratio of 63:12:25
(Figure 2A, Supplementary Table S3, and Supplementary
Figure S3A). However, concentrations of the butyrate-producing
families Lachnospiraceae (−1.1 log gene copies vs. in vivo)
and Ruminococcaceae (below detection limit) remained
low compared to caecal inoculum. Further, lower levels of
Lactobacillus spp. (−1.8 log gene copies) and higher levels of
Enterobacteriaceae (+3.9 log gene copies) were detected in the
eﬄuent samples compared to the caecal inoculum (Figure 2B
and Supplementary Table S4).
Other possible strategies to prevent the outgrowth of
Enterobacteriaceae are reducing the concentration of simple
carbohydrates in the nutritive medium (here: corn starch), and
decreasing the pH (from pH 7 to 5.8 during batch fermentation
and from pH 7 to 6.5 during continuous operation), since optimal
growth pH of these bacteria is close to neutrality (Supplementary
Table S1 and Table 1). After 19 days of continuous culture,
steady metabolite production was reached with higher total
metabolite production (154 ± 13 mM) compared to previous
model 3 (p < 0.05) and a AA:PA:BA ratio of 66:4:29 (Figure 2A,
Supplementary Table S3, and Supplementary Figure S3B). High
butyrate levels were observed in caecal inoculum (83 mM)
and reactor eﬄuent (33 mM), which can be associated with
high and comparable levels of butyrate-producing families
Ruminococcaceae (7.7 ± 0.1 log gene copies/mL and 7.5 log gene
copies/g, respectively) and Lachnospiraceae (9.4 ± 0.3 log gene
copies/mL and 10.5 log gene copies/g, respectively; Figure 2B
and Supplementary Table S4). However, the concentration of
Enterobacteriaceae remained high (+3.8 log gene copies/mL
compared to caecal inoculum) and Lactobacillus spp. remained
below the detection limit.
A recent study found that some bacterial populations within
Clostridiales order are positively associated with long RTs in
humans, which may also promote growth conditions for the
slow-growing bacterial populations in our model (Roager et al.,
2016). Therefore, in model 5 we assessed whether an increase in
RT from 9 h (model 4) to 12 h can prevent overgrowth of fast-
growing Enterobacteriaceae. A high total metabolite production
was obtained (158 ± 9 mM) with higher levels of propionate
(p< 0.05) and lower levels of the intermediate metabolite formate
(p < 0.05) compared to model 4 (Figure 2A, Supplementary
Figure S4, and Supplementary Table S3). The AA:PA:BA ratio
in vitro (65:14:22) was comparable with the ratio detected in the
caecal inoculum (62:9:28). Concentrations of potential butyrate-
producing bacterial markers Lachnospiraceae (8.2 ± 0.3 log gene
copies/mL vs. 10.1± 0.0 log gene copies/g) and Ruminococcaceae
(7.1 ± 0.3 log gene copies/mL vs. 8.3 ± 0.0 log gene 372
copies/g) were lower in eﬄuent samples compared with caecal
inoculum levels (Figure 2B and Supplementary Table S4).
Despite this, increased retention resulted in less overgrowth of
Enterobacteriaceae (5.7 ± 0.1 log gene copies/g caecal content
vs. 7.7 ± 0.1 log gene copies/mL model 5 eﬄuent) and no
severe loss of Lactobacillus spp. (8.4 ± 0.1 log gene copies/g
caecal content vs. 6.6 ± 0.1 log gene copies/mL model 5 eﬄuent)
compared to model 4.
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FIGURE 2 | Bacterial activity and composition of caecal inocula and reactor effluents of different models. (A) Concentrations of metabolites (mM) in caecal inocula
and reactor effluents of stabilization phases expressed as mean metabolite concentrations with standard error. (B) Quantification of key bacterial populations in
caecal inocula and fermentation samples of different models by qPCR and expressed as means ± SD log gene copies/g or mL when n > 1. BDL, below detection
limit of 4 log10 gene copies.
Frontiers in Microbiology | www.frontiersin.org 8 May 2019 | Volume 10 | Article 1166
fmicb-10-01166 May 27, 2019 Time: 17:10 # 9
Poeker et al. In vitro Caecal Murine Fermentation Model
As model 5 conditions reflected the metabolic and bacterial
concentrations of the mouse caecum adequately, an independent
repetition of model 5 was performed (starting from another
caecal microbiota inoculum; referred to as model 5∗). The
total fermentation metabolite production (161 ± 7 mM) was
comparable to levels in model 5 (Figure 2A and Supplementary
Table S3). Overall, the metabolite production in both model
5 and 5∗ was stable during continuous operation of 69 and
43 days, respectively (Supplementary Figures S4, S5). At the
bacterial marker level, comparable concentrations of Bacteroides
spp. and Akkermansia spp. were detected in model 5∗ eﬄuent
samples compared to its caecal inoculum (Supplementary
Table S4). Interestingly, the in vitro Akkermansia spp. levels
(5.7± 0.1 log gene copies/mL) reflected the lower concentrations
present in caecal inoculum (6.7 ± 0.1 log gene copies/g in
caecal inoculum 5∗ vs. 8.6 ± 0.1 log gene copies/g in caecal
inoculum 5). Enterobacteriaceae spp. (6.6 ± 0.3 log gene
copies/mL) and Lactobacillus spp. (8.5± 0.6 log gene copies/mL)
established at comparable levels to those detected in the caecal
inoculum (6.3 ± 0.1 log gene copies/g and 8.2 ± 0.2 log gene
copies/g, respectively).
Microbiota Analysis of Final in vitro
Continuous Fermentation Murine
Caecum Model
To assess the overall microbiota composition and diversity in
comparison to the caecal inocula, reactor eﬄuent microbiota
of model 5 and 5∗ were further analyzed by 16S rRNA gene
sequencing. The composition of reactor microbiota differed from
the caecal inoculum microbiota as indicated in a PCoA-biplot
on weighted and unweighted UniFrac distance (Figures 3A,B).
Furthermore, model 5 microbiota differed from model 5∗
microbiota as shown by a spatial separation and clustering in both
unweighted and weighted UniFrac PCoA biplots. The two caecal
inocula microbiota showed scattering in the unweighted UniFrac
PCoA, indicating qualitative differences in their composition.
The bacterial diversity within the reactor microbiota was lower
compared to the caecal inocula microbiota (Figure 3C). Both
the Shannon diversity-index that takes into account the number
of observed OTUs and their relative evenness and the observed
species diversity decreased from 5.2 for caecal inocula to 2.7± 0.6
for reactor eﬄuent samples and from 130 to 35, respectively.
Overall abundance shifts from in vivo to in vitro caecal
microbial communities occurred (Figures 3D,E). Compared
to the caecal inocula, the Bacteroidetes phylum abundance
increased while Firmicutes phylum abundance decreased in both
in vitro microbiota; this shift was most pronounced in model 5∗
(Figure 3D and Supplementary Table S5). Certain genera and
species from the caecal inoculum flourished in vitro, while others
became established at a lower abundance or below the detection
limit. This resulted in significant and large log2 fold changes in
abundance when comparing caecal inoculum to corresponding
fermentation samples using DeSeq2 analysis (Supplementary
Figures S6, S7). Taxa from Bacteroides, Anaerococcus and
unclassified Clostridiaceae genera were enriched in vitro in both
models with a log2 fold change exceeding 4. Some abundant
(>1%) taxa in the caecal inocula established at a lower abundance
(unclassified Clostridiales and Lactobacillus genera) or were not
detected (taxa from Muribaculaceae (S24-7) family).
Compositional differences between the two in vitro microbiota
were observed, which were in line with the quantitative
differences detected by qPCR (Supplementary Figure S8).
Model 5 in vitro microbiota was characterized by taxa
belonging to Akkermansia, Enterobacteriaceae, Parabacteroides,
and Clostridiaceae, while in model 5∗, in vitro microbiota taxa
belonging to Lactobacillus, Peptostreptococcaceae, Blautia, and
Anaerofilum established better compared to model 5.
We next predicted the gene content from the 16S rRNA
sequence data by PICRUSt (phylogenetic investigation of
communities by reconstruction of unobserved states) for
revealing potential functional differences between both in vitro-
and caecal inocula microbiota. Conserved metabolic and
functional KEGG pathways were observed in both microbiota
types (Supplementary Figure S9), indicating a similar
microbial functional potential between in vitro- and caecal
inocula microbiota.
DISCUSSION
In this study, we aimed to develop a continuous in vitro
fermentation model that reflects the metabolic activity and
phylogeny of healthy WT mouse caecal microbiota. An important
prerequisite for in vitro studies is the rational selection of
models and conditions, while keeping in mind that these
models can never completely represent reality (Lacroix et al.,
2015). Therefore, we followed a stepwise approach for model
development by adjusting parameters to reach fermentation
metabolite profiles and marker bacterial levels similar to the
in vivo situation.
During continuous operation a stable in vitro fermentation
with main fermentation metabolites acetate, propionate and
butyrate was reached, which is in line with in vivo measurements
in this and other studies reporting ratios of murine caecal
microbial fermentation metabolites (Burokas et al., 2017;
Krautkramer et al., 2017; Herrmann et al., 2018). In vivo,
the SCFA are continuous and efficiently absorbed by the
intestinal epithelium (Morrison and Preston, 2016), resulting in
an underestimation of the actual caecal fermentation capacity
based on caecal SCFA measurements. Accordingly, the total
SCFA concentrations in vitro were higher than in vivo because
absorption is not simulated. Hence, model values reflect the
total fermentation capacity of the modeled caecal microbiota.
First models showed a limited fermentation capacity, but
thanks to the optimization steps the total metabolite production
increased from 115 mM in model 1 to 159 mM and 161 mM
in model 5 and 5∗, respectively. Along with the improved
fermentation capacity, a simultaneous longer stabilization time of
the models was observed; this might be explained by the growth
and balance of a more complex microbiota reliant on cross-
feeding mechanisms. A lower pH during startup and continuous
operation (models 3–4) stimulated bacterial fermentation as
previously observed in human microbiota fermentation models
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FIGURE 3 | Microbial composition and diversity analysis in caecal inocula and reactor effluents of model 5 and 5∗. (A,B) Principle Coordinate Analysis (PCoA) of
caecal inocula and reactor microbiota based on unweighted (A) and weighted (B) UniFrac analysis matrix on OTU level. Each point represents a microbiota sample
from murine caecal content used as inoculum for model 5 (red N) and model 5∗ (blue I) or from stabilized reactor effluents of model 5 (orange ) and model 5∗
(green  ). (C) Alpha diversity measured by Shannon diversity index and observed species. The box depicts distribution of diversity index for caecal inocula and
fermentation samples. Boxes represent the interquartile range (IQR) between the 5th and 95th percentiles, respectively. (D,E) Microbial composition in caecal
samples of WT C57BL/6 mice obtained by 16S rRNA amplicon sequencing. Relative abundance at phylum and family level of caecal inocula and fermentation
samples of model 5 and 5∗. Data are mean ± SD. Values < 1% are summarized in the group «Others».
(Walker et al., 2005; Zihler et al., 2013). Increased RT (model
4–5) resulted in decreased accumulation of the intermediate
metabolites formate and lactate, and higher levels of branched
SCFA, which are specific markers for protein fermentation and
associated with long RTs (Davila et al., 2013; Tottey et al.,
2017). Succinate was after acetate, propionate and butyrate the
microbial metabolite detected at the highest concentrations in all
caecal murine fermentation models and their respective caecal
inocula. In humans, succinate is considered an intermediate
metabolite in the global intestinal microbiota fermentation
process (Macfarlane and Macfarlane, 2003), since several gut
bacteria can convert succinate to propionate or butyrate (Louis
and Flint, 2017). In mice, high levels of caecal succinate were
reported in response to dietary fiber treatment (Everard et al.,
2014) and high succinate levels have been demonstrated to
improve glucose metabolism via intestinal gluconeogenesis (De
Vadder et al., 2016). When sufficient carbohydrates are present,
Bacteroides taxa show reduced need to decarboxylate succinate;
thus succinate accumulates instead of propionate (Macy et al.,
1978). Furthermore, in Bifidobacteria succinate production is
associated with growth (Van Der Meulen et al., 2006), which may
explain the high levels detected in our continuous fermentation
model due to continuous supply of carbohydrates and therefore
growth of these bacteria. The qualitative assessment of the
predicted microbial functions by PICRUSt indicated that the
gene contents of most pathways were maintained in our model,
despite changes in abundances of bacterial populations. These
results also suggest that the reactor microbiota as a whole
did not change its functional fermentation potential, such as
metabolic cross-feeding pathways, from in vivo (caecal inoculum)
to in vitro (reactor).
The in vitro murine caecal microbiota was mainly composed
of the bacterial phyla Firmicutes and Bacteroidetes, both in the
range of in vivo caecal microbiota compositions, previously
reported (Ley et al., 2006; Clavel et al., 2016; Hugenholtz
and de Vos, 2017). However, there was a shift toward higher
Bacteroidetes levels compared to caecal inocula; similar shifts
were reported for in vitro human intestinal microbiota models
(Rajilic-Stojanovic et al., 2010; Van den Abbeele et al., 2010;
McDonald et al., 2013; Fehlbaum et al., 2015). The high levels
of complex carbohydrates in nutritive media used for intestinal
fermentation models may favor the growth of Bacteroidetes
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taxa, since they have a higher glycan-degrading capacity
compared to Firmicutes species (Mahowald et al., 2009). The
taxa within murine bacterial families that were maintained
in the in vitro fermentations belong to important functional
groups for intestinal fermentation such as primary fibrolytic
(Bacteroidaceae, Ruminococcaceae, Bifidobacteriaceae), glycolytic
(Lactobacillaceae, Enterococcaceae, Enterobacteriaceae) and
mucolytic (Verrucomicrobiaceae, Bacteroidaceae) bacteria; and
secondary butyrate- and propionate-producing bacteria
(Lachnospiraceae, Ruminococcaceae, Erysipelotrichaceae,
Rikenellaceae, Verrucomicrobiaceae) (Chassard and Lacroix,
2013). The prevalent murine intestinal bacterial family
Muribaculaceae (S24-7) was not maintained in our in vitro
model. Only recently, Lagkouvardos et al. (2016) succeeded to
isolate and cultivate the first strain of this family in a medium
containing meat and blood. Interestingly, a recent study reported
that this Muribaculaceae (S24-7) strain is extremely sensitive to
high osmolality (Tropini et al., 2018) and the higher osmolality
in our reactors compared to caecum may also explain its
low establishment in vitro. Further characterization of the
physiology and nutritional requirements of strains from the
Muribaculaceae family and other taxa that were not maintained
in vitro will be important to further optimize our murine
nutritive fermentation medium. Adjustments to nutritive
medium, pH and RT helped to control the in vitro levels of
Enterobacteriaceae, which often bloom in fermentation models
(Fehlbaum et al., 2015; McDonald et al., 2015) due to their
competitive advantage during initial colonization and balancing
of the fermentation model.
There was an important overall decrease in bacterial diversity
in vitro compared to the high caecal inoculum diversity, which
were in the range of published Shannon diversity indices ranging
from 4.5 to 6 (Holm et al., 2015; Hu et al., 2017). Such effects
were also observed in other in vitro fermentation models
inoculated with high diverse intestinal microbial communities
from humans (infants, adult and elderly) (Rajilic-Stojanovic
et al., 2010; Van den Abbeele et al., 2010; McDonald et al.,
2013; Feria-Gervasio et al., 2014; Poeker et al., 2018) and swine
(Tanner et al., 2014). In vitro models cannot simulate all the
conditions occurring in the host, which are not well-known
or cannot be mimicked such as immune response, variation in
feed rates and composition, hormonal and digestive secretions
(e.g., bile), feedback mechanisms, absorption and peristaltic
movements, all of which influence microbial diversity and
can only be an approximation of realistic conditions (Lacroix
et al., 2015). The well-controlled conditions in vitro may result
in a loss of redundant species or species thriving on specific
host secretions. Murine intestinal bacterial isolation efforts
(Lagkouvardos et al., 2016) offer the opportunity to identify
species-specific growth requirements and will allow adaptation
of fermentation conditions for their improved establishment
in vitro. Finally, the presence of transient bacteria, i.e., from
upper gastrointestinal tract, diet and ingested microbes due
to coprophagy, in the caecal inocula may also overestimate
the bacterial diversity of the resident caecal community.
By mimicking the murine caecal conditions, we obtained a
microbial community composed of caecal murine-derived
bacteria, with reduced complexity but resulting in a stable and
functional caecal fermentation.
Mouse experiments have gained attention as tool to study
the gut microbiota in health and disease. However, their poor
reproducibility within and between facilities was associated with
high variability among the mouse gut microbiota, which makes
it hard to draw robust conclusions (Laukens et al., 2015).
Factors contributing to the heterogeneity of the mouse gut
microbiota within a facility include differences in food intake
(Zarrinpar et al., 2014), maternal effects (Hufeldt et al., 2010),
hormones (Org et al., 2016), cage (Hildebrand et al., 2013),
presence of surrounding animals (Rausch et al., 2016), and other
stressors (Bangsgaard Bendtsen et al., 2012) and environmental
factors. To control for these factors, our strategy is to uncouple
the microbiota from the host and study it under very well-
controlled conditions (e.g., fermenter). In contrast to in vivo
models, in vitro models allow study of the dynamics of the
complex microbiota following manipulations, particularly to
follow production of in situ fermentation metabolites, which
are partly absorbed in vivo. Identified microbes or metabolites
that drive microbiota functionality can then be validated further
in vivo. Moreover, the continuous cultivated in vitro murine
caecal microbiota can be used as transplantation material to
study host–microbiota interactions in murine models of health
and disease. This approach is currently performed with pooled
murine fecal material, which is less controlled and available,
or with bacterial consortia of human- or mouse-derived strains
(Clavel et al., 2016). Recently the Oligo-Mouse-Microbiota
(Brugiroux et al., 2016), a mixture of up to 15 intestinal murine-
derived strains from the mouse intestinal bacterial collection
(Lagkouvardos et al., 2016), was established following a bottom-
up approach of rational strain selection. Alternatively, with
our novel murine caecal fermentation model we can follow
a top–down approach of creating functional different murine-
derived bacterial communities with higher diversity compared to
current consortia.
CONCLUSION
We showed that it is feasible to maintain a stable and simplified,
but yet representative in vitro murine microbiota in a continuous
murine caecal fermentation model inoculated with immobilized
caecal microbiota. Our simplified, yet representative in vitro
murine bacterial community showed a similar functionality
to inoculum microbiota. We demonstrated that it is feasible
to continuously cultivate caecal murine microbiota while
maintaining its overall functionality over a long time period. Our
model is a first step in the development of a mouse microbiota
model system. With the expected increased knowledge of mouse
gut isolates, further improvements of our murine in vitro model
can be carried out by fine-tuning operational or nutritional
requirements, and hence to increase preservation of microbial
diversity in our model. In addition, our model can be expanded
further with second-stage reactors, continuously inoculated with
reactor eﬄuent to allow parallel testing of different manipulations
on the same microbiota. Hence, our novel in vitro model is
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a promising tool for studying the murine microbe–microbe
interactions in response to biotic or abiotic factors that are linked
to gut microbial functionality and structure.
ETHICS STATEMENT
Mouse experiments were conducted according to Swiss
animal welfare legislation, and the local veterinary office
approved all procedures (Veterinäramt des Kantons Zürich;
Nr. ZH220/2016).
AUTHOR CONTRIBUTIONS
SP, AG, TW, and CL conceived the experiments. SP, AG, and
TW conducted the experiments. SP and AG analyzed 16S rRNA
sequence, HPLC and qPCR data. SP prepared the figures. SP, AG,
MRS, MS, and CL interpreted the results. SP, AG, and CL wrote
the manuscript. MRS and MS bred and sacrificed the mice. All
authors reviewed the manuscript.
FUNDING
This study was funded by the Swiss National Science Foundation
(Sinergia Project No. CRSII3_154488).
ACKNOWLEDGMENTS
The authors would like to thank Annica Jucker, Helen
Hobi, and Jasmin Hirt for technical assistance, Alfonso
Die for the technical assistance during SCFA analysis
and Anna Greppi and people from Genetic Diversity
Center at ETH Zurich for support during 16S amplicon
sequencing preparation.
SUPPLEMENTARY MATERIAL




Bangsgaard Bendtsen, K. M., Krych, L., Sørensen, D. B., Pang, W., Nielsen, D. S.,
Josefsen, K., et al. (2012). Gut microbiota composition is correlated to grid
floor induced stress and behavior in the BALB/c mouse. PLoS One 7:e46231.
doi: 10.1371/journal.pone.0046231
Bourriaud, C., Robins, R. J., Martin, L., Kozlowski, F., Tenailleau, E., Cherbut,
C., et al. (2005). Lactate is mainly fermented to butyrate by human intestinal
microfloras but inter-individual variation is evident. J. Appl. Microbiol. 99,
201–212. doi: 10.1111/j.1365-2672.2005.02605.x
Brugiroux, S., Beutler, M., Pfann, C., Garzetti, D., Ruscheweyh, H.-J.,
Ring, D., et al. (2016). Genome-guided design of a defined mouse
microbiota that confers colonization resistance against Salmonella enterica
serovar Typhimurium. Nat. Microbiol. 2:16215. doi: 10.1038/nmicrobiol.
2016.215
Bryant, C. D. (2011). The blessings and curses of C57BL/6 substrains in mouse
genetic studies. Ann. N. Y. Acad. Sci. 1245, 31–33. doi: 10.1111/j.1749-6632.
2011.06325.x
Bryant, M. P. (1959). Bacterial species of the rumen. Bacteriol. Rev. 23, 125–153.
Burokas, A., Arboleya, S., Moloney, R. D., Peterson, V. L., Murphy, K., Clarke, G.,
et al. (2017). Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic
and antidepressant-like effects and reverse the impact of chronic stress in mice.
Biol. Psychiatry 82, 472–487. doi: 10.1016/j.biopsych.2016.12.031
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D.,
Costello, E. K., et al. (2010). QIIME allows analysis of high-throughput
community sequencing data. Nat. Methods 7, 335–336. doi: 10.1038/nmeth.
f.303
Champy, M. F., Selloum, M., Zeitler, V., Caradec, C., Jung, B., Rousseau, S., et al.
(2008). Genetic background determines metabolic phenotypes in the mouse.
Mamm. Genome 19, 318–331. doi: 10.1007/s00335-008-9107-z
Chassard, C., and Lacroix, C. (2013). Carbohydrates and the human gut
microbiota. Curr. Opin. Clin. Nutr. Metab. Care 16, 453–460. doi: 10.1097/
MCO.0b013e3283619e63
Clavel, T., Lagkouvardos, I., Blaut, M., and Stecher, B. (2016). The mouse gut
microbiome revisited: from complex diversity to model ecosystems. Int. J. Med.
Microbiol. 306, 316–327. doi: 10.1016/j.ijmm.2016.03.002
Clavel, T., Lagkouvardos, I., and Stecher, B. (2017). From complex gut communities
to minimal microbiomes via cultivation. Curr. Opin. Microbiol. 38, 148–155.
doi: 10.1016/j.mib.2017.05.013
Cornick, S., Tawiah, A., and Chadee, K. (2015). Roles and regulation of the
mucus barrier in the gut. Tissue Barriers 3:e982426. doi: 10.4161/21688370.
2014.982426
Dahlqvist, A., and Thomson, D. L. (1963a). The digestion and absorption of
maltose and trehalose by the intact rat. Acta Physiol. Scand. 59, 111–125. doi:
10.1111/j.1748-1716.1963.tb02728.x
Dahlqvist, A., and Thomson, D. L. (1963b). The digestion and absorption of
sucrose by the intact rat. J. Physiol. 167, 193–209. doi: 10.1113/jphysiol.1963.
sp007141
Davila, A. M., Blachier, F., Gotteland, M., Andriamihaja, M., Benetti, P. H., Sanz,
Y., et al. (2013). Re-print of “intestinal luminal nitrogen metabolism: role of the
gut microbiota and consequences for the host.”. Pharmacol. Res. 69, 114–126.
doi: 10.1016/j.phrs.2013.01.003
De Vadder, F., Kovatcheva-Datchary, P., Zitoun, C., Duchampt, A., Bäckhed, F.,
and Mithieux, G. (2016). Microbiota-produced succinate improves glucose
homeostasis via intestinal gluconeogenesis. Cell Metab. 24, 151–157. doi: 10.
1016/j.cmet.2016.06.013
Dostal, A., Lacroix, C., Bircher, L., Pham, V. T., Follador, R., Zimmermann, M. B.,
et al. (2015). Iron modulates butyrate production by a child gut microbiota In
Vitro. mBio 6:e01453-15. doi: 10.1128/mBio.01453-15
Edgar, R. C. (2013). UPARSE: highly accurate OTU sequences from microbial
amplicon reads. Nat. Methods 10, 996–998. doi: 10.1038/nmeth.2604
Everard, A., Lazarevic, V., Gaïa, N., Johansson, M., Ståhlman, M., Backhed, F., et al.
(2014). Microbiome of prebiotic-treated mice reveals novel targets involved in
host response during obesity. ISME J. 8, 2116–2130. doi: 10.1038/ismej.2014.45
Fehlbaum, S., Chassard, C., Haug, M. C., Fourmestraux, C., Derrien, M., and
Lacroix, C. (2015). Design and investigation of PolyFermS In Vitro continuous
fermentation models inoculated with immobilized fecal microbiota mimicking
the elderly colon. PLoS One 10:e0142793. doi: 10.1371/journal.pone.0142793
Feria-Gervasio, D., Tottey, W., Gaci, N., Alric, M., Cardot, J.-M., Peyret, P., et al.
(2014). Three-stage continuous culture system with a self-generated anaerobia
to study the regionalized metabolism of the human gut microbiota. J. Microbiol.
Methods 96, 111–118. doi: 10.1016/j.mimet.2013.11.015
Flint, H. J., Scott, K. P., Louis, P., and Duncan, S. H. (2012). The role of the gut
microbiota in nutrition and health. Nat. Rev. Gastroenterol. Hepatol. 9, 577–589.
doi: 10.1038/nrgastro.2012.156
Freter, R., Stauffer, E., Cleven, D., Holdeman, L. V., and Moore, W. E. (1983).
Continuous-flow cultures as in vitro models of the ecology of large intestinal
flora. Infect. Immun. 39, 666–675.
Frontiers in Microbiology | www.frontiersin.org 12 May 2019 | Volume 10 | Article 1166
fmicb-10-01166 May 27, 2019 Time: 17:10 # 13
Poeker et al. In vitro Caecal Murine Fermentation Model
Geirnaert, A., Wang, J., Tinck, M., Steyaert, A., Van den Abbeele, P., Eeckhaut, V.,
et al. (2015). Interindividual differences in response to treatment with butyrate-
producing Butyricicoccus pullicaecorum 25-3T studied in an in vitro gut model.
FEMS Microbiol. Ecol. 91:fiv054. doi: 10.1093/femsec/fiv054
Hamaguchi, Y., Tahara, Y., Kuroda, H., Haraguchi, A., and Shibata, S. (2015).
Entrainment of mouse peripheral circadian clocks to < 24 h feeding/fasting
cycles under 24 h light/dark conditions. Sci. Rep. 5:14207. doi: 10.1038/
srep14207
Herrmann, E., Young, W., Reichert-Grimm, V., Weis, S., Riedel, C., Rosendale,
D., et al. (2018). In Vivo assessment of resistant starch degradation by the
caecal microbiota of mice using RNA-based stable isotope probing—a proof-
of-principle study. Nutrients 10:179. doi: 10.3390/nu10020179
Herrmann, E., Young, W., Rosendale, D., Conrad, R., Riedel, C. U., and Egert, M.
(2017). Determination of resistant starch assimilating bacteria in fecal samples
of mice by In vitro RNA-based stable isotope probing. Front. Microbiol. 8:1331.
doi: 10.3389/fmicb.2017.01331
Hildebrand, F., Nguyen, T. L. A., Brinkman, B., Yunta, R. G., Cauwe, B.,
Vandenabeele, P., et al. (2013). Inflammation-associated enterotypes, host
genotype, cage and inter-individual effects drive gut microbiota variation in
common laboratory mice. Genome Biol. 14:R4. doi: 10.1186/gb-2013-14-1-r4
Holm, J. B., Sorobetea, D., Kiilerich, P., Ramayo-Caldas, Y., Estellé, J., Ma, T., et al.
(2015). Chronic trichuris muris infection decreases diversity of the intestinal
microbiota and concomitantly increases the abundance of lactobacilli. PLoS
One 10:e0125495. doi: 10.1371/journal.pone.0125495
Hu, J., Luo, H., Jiang, Y., and Chen, P. (2017). Dietary capsaicin and antibiotics
act synergistically to reduce non-alcoholic fatty liver disease induced by
high fat diet in mice. Oncotarget 8, 38161–38175. doi: 10.18632/oncotarget.
16975
Hufeldt, M. R., Nielsen, D. S., Vogensen, F. K., Midtvedt, T., and
Hansen, A. K. (2010). Family relationship of female breeders reduce
the systematic inter-individual variation in the gut microbiota of
inbred laboratory mice. Lab. Anim. 44, 283–289. doi: 10.1258/la.2010.
010058
Hugenholtz, F., and de Vos, W. M. (2017). Mouse models for human intestinal
microbiota research: a critical evaluation. Cell. Mol. Life Sci. 75, 149–160. doi:
10.1007/s00018-017-2693-8
Kamada, N., Chen, G. Y., Inohara, N., and Nunez, G. (2013). Control of pathogens
and pathobionts by the gut microbiota. Nat. Immunol. 14, 685–690. doi: 10.
1038/ni.2608
Kerr, K. R., Kappen, K. L., Garner, L. M., and Swanson, K. S. (2014). Commercially
available avian and mammalian whole prey diet items targeted for consumption
by managed exotic and domestic pet felines: macronutrient, mineral, and long-
chain fatty acid composition. Zoo Biol. 33, 327–335. doi: 10.1002/zoo.21147
Krautkramer, K. A., Kreznar, J. H., Romano, K. A., Vivas, E. I., Barrett-wilt,
G. A., Rabaglia, M. E., et al. (2017). Diet-microbiota interactions mediate global
epigenetic programming in multiple host tissues. Mol. Cell 64, 982–992. doi:
10.1016/j.molcel.2016.10.025
Krych, Ł., Kot, W., Bendtsen, K. M. B., Hansen, A. K., Vogensen, F. K., and Nielsen,
D. S. (2018). Have you tried spermine? a rapid and cost-effective method to
eliminate dextran sodium sulfate inhibition of PCR and RT-PCR. J. Microbiol.
Methods 144, 1–7. doi: 10.1016/j.mimet.2017.10.015
Lacroix, C., de Wouters, T., and Chassard, C. (2015). Integrated multi-scale
strategies to investigate nutritional compounds and their effect on the gut
microbiota. Curr. Opin. Biotechnol. 32, 149–155. doi: 10.1016/j.copbio.2014.12.
009
Lagkouvardos, I., Pukall, R., Abt, B., Foesel, B. U., Meier-Kolthoff, J. P.,
Kumar, N., et al. (2016). The mouse intestinal bacterial collection (miBC)
provides host-specific insight into cultured diversity and functional potential
of the gut microbiota. Nat. Microbiol. 1:16131. doi: 10.1038/nmicrobiol.
2016.131
Langille, M. G. I., Zaneveld, J., Caporaso, J. G., McDonald, D., Knights, D., Reyes,
J. A., et al. (2013). Predictive functional profiling of microbial communities
using 16S rRNA marker gene sequences. Nat. Biotechnol. 31, 814–821. doi:
10.1038/nbt.2676
Laukens, D., Brinkman, B. M., Raes, J., De Vos, M., and Vandenabeele, P.
(2015). Heterogeneity of the gut microbiome in mice: guidelines for optimizing
experimental design. FEMS Microbiol. Rev. 40, 117–132. doi: 10.1093/femsre/
fuv036
Lee, T. T., Huang, Y. F., Chiang, C. C., Chung, T. K., Chiou, P. W., and Yu, B.
(2011). Starch characteristics and their influences on in vitro and pig prececal
starch digestion. J. Agric. Food Chem. 59, 7353–7359. doi: 10.1021/jf200402u
Ley, R. E., Backhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., and Gordon,
J. I. (2005). Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U.S.A.
102, 11070–11075. doi: 10.1073/pnas.0504978102
Ley, R. E., Peterson, D. A., and Gordon, J. I. (2006). Ecological and evolutionary
forces shaping microbial diversity in the human intestine. Cell 124, 837–848.
doi: 10.1016/j.cell.2006.02.017
Li, L., Zhang, X., Ning, Z., Mayne, J., Moore, J. I., Butcher, J., et al. (2018).
Evaluating In Vitro culture medium of gut microbiome with orthogonal
experimental design and a metaproteomics approach. J. Proteome Res. 17,
154–163. doi: 10.1021/acs.jproteome.7b00461
Louis, P., and Flint, H. J. (2017). Formation of propionate and butyrate by the
human colonic microbiota. Environ. Microbiol. 19, 29–41. doi: 10.1111/1462-
2920.13589
Love, M. I., Huber, W., and Anders, S. (2014). Moderated estimation of fold
change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 1–21.
doi: 10.1186/s13059-014-0550-8
Macfarlane, G. T., Macfarlane, S., and Gibson, G. R. (1998). Validation of a
three-stage compound continuous culture system for investigating the effect of
retention time on the ecology and metabolism of bacteria in the human colon.
Microb. Ecol. 35, 180–187. doi: 10.1007/s002489900072
Macfarlane, S., and Macfarlane, G. T. (2003). Regulation of short-chain fatty acid
production. Proc. Nutr. Soc. 62, 67–72. doi: 10.1079/PNS2002207
Macy, J. M., Ljungdahl, L. G., and Gottschalk, G. (1978). Pathway of succinate and
propionate formation in Bacteroides fragilis. J. Bacteriol. 134, 84–91.
Mahowald, M. A., Rey, F. E., Seedorf, H., Turnbaugh, P. J., Fulton, R. S., Wollam,
A., et al. (2009). Characterizing a model human gut microbiota composed of
members of its two dominant bacterial phyla. Proc. Natl. Acad. Sci. U.S.A. 106,
5859–5864. doi: 10.1073/pnas.0901529106
McDonald, J. A. K., Fuentes, S., Schroeter, K., Heikamp-deJong, I., Khursigara,
C. M., de Vos, W. M., et al. (2015). Simulating distal gut mucosal and luminal
communities using packed-column biofilm reactors and an in vitro chemostat
model. J. Microbiol. Methods 108, 36–44. doi: 10.1016/j.mimet.2014.11.007
McDonald, J. A. K., Schroeter, K., Fuentes, S., Heikamp-deJong, I., Khursigara,
C. M., de Vos, W. M., et al. (2013). Evaluation of microbial community
reproducibility, stability and composition in a human distal gut chemostat
model. J. Microbiol. Methods 95, 167–174. doi: 10.1016/j.mimet.2013.08.008
McMurdie, P. J., and Holmes, S. (2014). Waste not, want not: why rarefying
microbiome data is inadmissible. PLoS Comput. Biol. 10:e1003531. doi: 10.1371/
journal.pcbi.1003531
Michel, C., Kravtchenko, T. P., David, A., Gueneau, S., Kozlowski, F., and Cherbut,
C. (1998). In vitro prebiotic effects of Acacia gums onto the human intestinal
microbiota depends on both botanical origin and environmental pH. Anaerobe
4, 257–266. doi: 10.1006/anae.1998.0178
Morrison, D. J., and Preston, T. (2016). Formation of short chain fatty acids by
the gut microbiota and their impact on human metabolism. Gut Microbes 7,
189–200. doi: 10.1080/19490976.2015.1134082
Nguyen, T. L. A., Vieira-Silva, S., Liston, A., and Raes, J. (2015). How informative
is the mouse for human gut microbiota research? Dis. Model. Mech. 8, 1–16.
doi: 10.1242/dmm.017400
Org, E., Mehrabian, M., Parks, B. W., Shipkova, P., Liu, X., Drake, T. A.,
et al. (2016). Sex differences and hormonal effects on gut microbiota
composition in mice. Gut Microbes 7, 313–322. doi: 10.1080/19490976.2016.12
03502
Payne, A. N., Zihler, A., Chassard, C., and Lacroix, C. (2012). Advances and
perspectives in in vitro human gut fermentation modeling. Trends Biotechnol.
30, 17–25. doi: 10.1016/j.tibtech.2011.06.011
Pham, V. T., Lacroix, C., Braegger, C. P., and Chassard, C. (2017). Lactate-utilizing
community is associated with gut microbiota dysbiosis in colicky infants. Sci.
Rep. 7:11176. doi: 10.1038/s41598-017-11509-1
Poeker, S. A., Geirnaert, A., Berchtold, L., Greppi, A., Krych, L., Steinert, R. E., et al.
(2018). Understanding the prebiotic potential of different dietary fibers using
an in vitro continuous adult fermentation model (PolyFermS). Sci. Rep. 8, 1–12.
doi: 10.1038/s41598-018-22438-y
Rajilic-Stojanovic, M., Maathuis, A., Heilig, H. G., Venema, K., de Vos, W. M., and
Smidt, H. (2010). Evaluating the microbial diversity of an in vitro model of the
Frontiers in Microbiology | www.frontiersin.org 13 May 2019 | Volume 10 | Article 1166
fmicb-10-01166 May 27, 2019 Time: 17:10 # 14
Poeker et al. In vitro Caecal Murine Fermentation Model
human large intestine by phylogenetic microarray analysis. Microbiology 156,
3270–3281. doi: 10.1099/mic.0.042044-0
Rausch, P., Basic, M., Batra, A., Bischoff, S. C., Blaut, M., Clavel, T., et al. (2016).
Analysis of factors contributing to variation in the C57BL/6J fecal microbiota
across German animal facilities. Int. J. Med. Microbiol. 306, 343–355. doi: 10.
1016/j.ijmm.2016.03.004
Roager, H. M., Hansen, L. B., Bahl, M. I., Frandsen, H. L., Carvalho, V., Gobel, R. J.,
et al. (2016). Colonic transit time is related to bacterial metabolism and mucosal
turnover in the gut. Nat. Microbiol. 1:16093. doi: 10.1038/nmicrobiol.2016.93
Robles Alonso, V., and Guarner, F. (2013). Linking the gut microbiota to human
health. Br. J. Nutr. 109(Suppl.), S21–S26. doi: 10.1017/S0007114512005235
Round, J. L., and Mazmanian, S. K. (2009). The gut microbiome shapes intestinal
immune responses during health and disease. Nat. Rev. Immunol. 9, 313–323.
doi: 10.1038/nri2515
Round, J. L., and Palm, N. W. (2018). Causal effects of the microbiota
on immune-mediated diseases. Sci. Immunol. 3:eaao1603. doi: 10.1126/
sciimmunol.aao1603
Salyer, J., Park, S. H., Ricke, S. C., and Lee, S. K. (2013). Analysis of microbial
populations and metabolism of anthocyanins by mice gut microflora fed with
blackberry powder. J. Nutr. Food Sci. 3:178. doi: 10.4172/2155-9600.1000178
Tahara, Y., Yamazaki, M., Sukigara, H., Motohashi, H., Sasaki, H., Miyakawa, H.,
et al. (2018). Gut microbiota-derived short chain fatty acids induce circadian
clock entrainment in mouse peripheral tissue. Sci. Rep. 8, 1–12. doi: 10.1038/
s41598-018-19836-7
Tanner, S. A., Zihler Berner, A., Rigozzi, E., Grattepanche, F., Chassard, C., Lacroix,
C., et al. (2014). In Vitro continuous fermentation model (PolyFermS) of the
swine proximal colon for simultaneous testing on the same gut microbiota.
PLoS One 9:e94123. doi: 10.1371/journal.pone.0094123
Tao, Y., Hu, X., Zhu, X., Jin, H., Xu, Z., Tang, Q., et al. (2016). Production of
butyrate from lactate by a newly isolated clostridium sp. BPY5. Appl. Biochem.
Biotechnol. 179, 361–374. doi: 10.1007/s12010-016-1999-6
Tottey, W., Feria-Gervasio, D., Gaci, N., Laillet, B., Pujos, E., Martin, J.-F., et al.
(2017). Colonic transit time is a driven force of the gut microbiota composition
and metabolism: in vitro evidence. J. Neurogastroenterol. Motil. 23, 124–134.
doi: 10.5056/jnm16042
Tropini, C., Moss, E. L., Merrill, B. D., Ng, K. M., Higginbottom, S. K., Casavant,
E. P., et al. (2018). Transient osmotic perturbation causes long-term alteration
to the gut microbiota. Cell 173, 1742–1754.e17. doi: 10.1016/j.cell.2018.05.008
Uhl, E. W., and Warner, N. J. (2015). Mouse models as predictors of human
responses: evolutionary medicine. Curr. Pathobiol. Rep. 3, 219–223. doi: 10.
1007/s40139-015-0086-y
Van den Abbeele, P., Grootaert, C., Marzorati, M., Possemiers, S., Verstraete, W.,
Gérard, P., et al. (2010). Microbial community development in a dynamic gut
model is reproducible, colon region specific, and selective for Bacteroidetes and
Clostridium cluster IX. Appl. Environ. Microbiol. 76, 5237–5246. doi: 10.1128/
AEM.00759-10
Van Der Meulen, R., Adriany, T., Verbrugghe, K., and De Vuyst, L. (2006). Kinetic
analysis of bifidobacterial metabolism reveals a minor role for succinic acid
in the regeneration of NAD+ through its growth-associated production. Appl.
Environ. Microbiol. 72, 5204–5210. doi: 10.1128/AEM.00146-06
van Zanten, G. C., Krych, L., Roytio, H., Forssten, S., Lahtinen, S. J., Abu Al-Soud,
W., et al. (2014). Synbiotic Lactobacillus acidophilus NCFM and cellobiose does
not affect human gut bacterial diversity but increases abundance of lactobacilli,
bifidobacteria and branched-chain fatty acids: a randomized, double-blinded
cross-over trial. FEMS Microbiol. Ecol. 90, 225–236. doi: 10.1111/1574-6941.
12397
Walker, A. W., Duncan, S. H., McWilliam Leitch, E. C., Child, M. W., and Flint,
H. J. (2005). pH and peptide supply can radically alter bacterial populations
and short-chain fatty acid ratios within microbial communities from the human
colon. Appl. Envinron. Microbiol. 71, 3692–3700. doi: 10.1128/AEM.71.7.3692-
3700.2005
Werner, J. J., Koren, O., Hugenholtz, P., DeSantis, T. Z., Walters, W. A., Caporaso,
J. G., et al. (2012). Impact of training sets on classification of high-throughput
bacterial 16s rRNA gene surveys. ISME J. 6, 94–103. doi: 10.1038/ismej.2011.82
Xiao, L., Feng, Q., Liang, S., Sonne, S. B., Xia, Z., Qiu, X., et al. (2015). A catalog of
the mouse gut metagenome. Nat. Biotechnol. 33, 1103–1108. doi: 10.1038/nbt.
3353
Zarrinpar, A., Chaix, A., Yooseph, S., and Panda, S. (2014). Diet and feeding pattern
affect the diurnal dynamics of the gut microbiome. Cell Metab. 20, 1006–1017.
doi: 10.1016/j.cmet.2014.11.008
Zihler, B. A., Fuentes, S., Dostal, A., Payne, A. N., Vazquez Gutierrez, P., Chassard,
C., et al. (2013). Novel Polyfermentor intestinal model (PolyFermS) for
controlled ecological studies: validation and effect of pH. PLoS One 8:e77772.
doi: 10.1371/journal.pone.0077772
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 Poeker, Lacroix, de Wouters, Spalinger, Scharl and Geirnaert.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 14 May 2019 | Volume 10 | Article 1166
